new fda-approved targeted drug for treatment-resistant, er positive her2 negative breast cancer
Published 6 months ago • 2.7K plays • Length 15:00Download video MP4
Download video MP3
Similar videos
-
21:57
new targeted therapy options for er positive, her2 negative, advanced breast cancer
-
0:41
new drug approvals for metastatic breast cancer
-
0:27
fda approves new breast cancer treatment
-
4:06
fda approves kisqali / ribociclib for early high-risk breast cancer esmo 2024
-
6:10
fda-approved chinese cancer drug to cost 30 times more
-
21:19
estrogen receptors & her2/neu receptors in breast cancer (a tutorial from oster oncology)
-
1:41
fda expands approval for drug to treat early-stage breast cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
2:23
fda approves new drug for metastatic breast cancer
-
3:00
fda expands approval of breast cancer drug kisqali: what to know
-
13:38
breakthrough: inavolisib combo wins fda nod for breast cancer
-
5:31
fda d.i.s.c.o.: olaparib for gbrcam her2-negative metastatic breast cancer
-
3:05
pi3k inhibitors for the treatment of brain metastases in her2-negative breast cancer
-
1:17
promising breast cancer drug approved by the fda
-
3:00
new treatment option for women with advanced breast cancer | ucla vital signs
-
1:58
fda approves the first cancer drug targeting a tumor solely based on its dna | nbc nightly news
-
7:18
newly approved agents for her2 breast cancer
-
1:17
new breast cancer clinical trial: aspirin for node positive her2 negative breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
2:33
fda expands approval of early breast cancer drug
-
1:29
drug repurposing in her2 breast cancer